News
03-06-2014, 03:10 AM
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
More... (http://www.medicalnewstoday.com/releases/273535.php)
More... (http://www.medicalnewstoday.com/releases/273535.php)